Published in Thorax on June 01, 1996
Proteases and cystic fibrosis. Int J Biochem Cell Biol (2008) 1.25
Matrix metalloproteases in BAL fluid of patients with cystic fibrosis and their modulation by treatment with dornase alpha. Thorax (2002) 1.13
The protease-antiprotease battle in the cystic fibrosis lung. J R Soc Med (1999) 0.90
Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N Engl J Med (1994) 7.98
Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med (1995) 6.56
Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet (1993) 6.39
Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum. Proc Natl Acad Sci U S A (1990) 2.99
Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line. J Clin Invest (1992) 2.62
Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis. Lancet (1993) 2.50
Granulocyte neutral proteases and Pseudomonas elastase as possible causes of airway damage in patients with cystic fibrosis. J Infect Dis (1984) 2.02
Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis. J Clin Invest (1984) 1.86
Medium term treatment of stable stage cystic fibrosis with recombinant human DNase I. Thorax (1995) 1.72
Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis. A potential mechanism for the recruitment and activation of neutrophils in lung fibrosis. J Clin Invest (1991) 1.66
Complement receptor expression on neutrophils at an inflammatory site, the Pseudomonas-infected lung in cystic fibrosis. J Clin Invest (1989) 1.44
Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis. A phase 1 study. JAMA (1992) 1.43
Cystic fibrosis lung inflammation: early, sustained, and severe. Am J Respir Crit Care Med (1995) 1.36
Inflammation in the lung in cystic fibrosis. A vicious cycle that does more harm than good? Clin Rev Allergy (1991) 1.26
Levels of free granulocyte elastase in bronchial secretions from patients with cystic fibrosis: effect of antimicrobial treatment against Pseudomonas aeruginosa. J Infect Dis (1986) 1.19
Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity. Pediatr Res (1986) 1.17
Two years experience with recombinant human DNase I in the treatment of pulmonary disease in cystic fibrosis. Respir Med (1995) 1.13
alpha 1-Proteinase inhibitor, elastase activity, and lung disease severity in cystic fibrosis. Am Rev Respir Dis (1993) 1.08
Bronchospasm after inhalation of pancreatic dornase. Am Rev Respir Dis (1968) 1.06
In-vitro evaluation of effect of enzymes on tracheobronchial secretions from patients withcystic fibrosis. Pediatrics (1961) 1.05
SUBSTRATE SPECIFICITY OF PROTEASE ACTIVITIES IN PURULENT SPUTUM. Lab Invest (1965) 0.95
Dornase aerosol effect on sputum viscosity in cases of cystic fibrosis. JAMA (1968) 0.95
Human recombinant DNase in cystic fibrosis. J R Soc Med (1995) 0.86
Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med (2001) 4.85
Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med (1978) 4.35
Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. N Engl J Med (1996) 4.25
Cancer in the offspring of radiation workers: a record linkage study. BMJ (1997) 3.13
Meconium ileus equivalent in association with nebulised ipratropium bromide in cystic fibrosis. Lancet (1990) 2.56
Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med (1997) 2.55
Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Arch Intern Med (1999) 2.44
Effects of mental stress on myocardial ischemia during daily life. JAMA (1997) 2.30
Randomised trial of magnesium in in-hospital cardiac arrest. Duke Internal Medicine Housestaff. Lancet (1997) 2.30
Mental stress--induced myocardial ischemia and cardiac events. JAMA (1996) 2.20
Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients. Thorax (1997) 2.19
Total sputum nitrate plus nitrite is raised during acute pulmonary infection in cystic fibrosis. Am J Respir Crit Care Med (1998) 1.84
Hypoxaemia during chest physiotherapy in patients with cystic fibrosis. Ir J Med Sci (1986) 1.74
Chronic eosinophilic pneumonia. A long-term follow-up of 12 patients. Chest (1993) 1.73
Phosphorylation of subunit proteins of intermediate filaments from chicken muscle and nonmuscle cells. Proc Natl Acad Sci U S A (1979) 1.72
Adverse cardiac effects of salt with fludrocortisone in hypertension. Hypertension (2001) 1.70
Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol (1997) 1.62
Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol (1996) 1.61
Genetic variants of microsomal epoxide hydrolase and glutamate-cysteine ligase in COPD. Eur Respir J (2008) 1.59
Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE): design and rationale. Am Heart J (2001) 1.55
Inotropic therapy for heart failure: an evidence-based approach. Am Heart J (2001) 1.55
Etiology of large pericardial effusions. Am J Med (1993) 1.53
Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up. J Am Coll Cardiol (2001) 1.51
Long-term results of surgery for bullous emphysema. J Thorac Cardiovasc Surg (1974) 1.46
Variation in the tumour necrosis factor gene is not associated with susceptibility to COPD. Eur Respir J (2007) 1.45
Phosphorylation of intermediate filament proteins by cAMP-dependent protein kinases. Cell (1981) 1.44
Cotrimoxazole and folate metabolism. Lancet (1976) 1.40
The remarkable structural and functional organization of the eukaryotic pyruvate dehydrogenase complexes. Proc Natl Acad Sci U S A (2001) 1.40
Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy. Am J Cardiol (2001) 1.38
Gender differences in survival in advanced heart failure. Insights from the FIRST study. Circulation (1999) 1.36
Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain. Radiology (1982) 1.31
Bronchiolitis and bronchitis in connective tissue disease. A possible relationship to the use of penicillamine. JAMA (1979) 1.28
Desmin- and vimentin-containing filaments and their role inthe assembly of the Z disk in muscle cells. Cold Spring Harb Symp Quant Biol (1982) 1.25
Evaluation of "electronic" spirometers. N Engl J Med (1973) 1.23
Serotonin stimulates mitogen-activated protein kinase activity through the formation of superoxide anion. Am J Physiol (1999) 1.22
Extension of the Drosophila lifespan by overexpression of a protein repair methyltransferase. Proc Natl Acad Sci U S A (2001) 1.22
Sarcoidosis and lymphoma in the same patient. Postgrad Med J (1983) 1.21
Socioeconomic status and telomere length: the West of Scotland Coronary Prevention Study. J Epidemiol Community Health (2009) 1.19
Progesterone induces a rapid increase in [Ca2+]in of Xenopus laevis oocytes. Proc Natl Acad Sci U S A (1980) 1.18
Effectiveness of once-nightly dosing of extended-release niacin alone and in combination for hypercholesterolemia. Am J Cardiol (1998) 1.18
Kinetic analysis of amino acid pools and protein synthesis in amphibian oocytes and embryos. Dev Biol (1978) 1.16
Ca2+-free calmodulin and calmodulin damaged by in vitro aging are selectively degraded by 26 S proteasomes without ubiquitination. J Biol Chem (2000) 1.15
Matrix metalloproteases and lung disease. Thorax (1994) 1.13
The effect of mild to moderate dementia on the Geriatric Depression Scale and on the General Health Questionnaire. Age Ageing (1990) 1.12
Reasons for underuse of angiotensin-converting enzyme inhibitors in patients with heart failure and left ventricular dysfunction. Am J Cardiol (1997) 1.11
Three cases of paradoxical vocal cord adduction followed up over a 10-year period. Chest (1993) 1.11
Cystic fibrosis and seizures. Lancet (1991) 1.11
Elastin and collagen remodeling in emphysema. A scanning electron microscopy study. Am J Pathol (1996) 1.10
Calcium, potassium, and sodium exchange by full-grown and maturing Xenopus laevis oocytes. Dev Biol (1977) 1.10
Effect of a failed distal reconstruction on the level of amputation. Am J Surg (1990) 1.09
A prospective trial of subxiphoid pericardiotomy in the diagnosis and treatment of large pericardial effusion. A follow-up report. Ann Surg (1993) 1.09
Migration of neutrophils across human pulmonary endothelial cells is not blocked by matrix metalloproteinase or serine protease inhibitors. Am J Respir Cell Mol Biol (1999) 1.08
Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors. Pharmacol Res (2001) 1.08
Systemic and pulmonary oxidative stress in idiopathic pulmonary fibrosis. Free Radic Biol Med (1999) 1.07
Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF. Eur Respir J (2002) 1.07
Single-dose effects of marihuana smoke. Bronchial dynamics and respiratory-center sensitivity in normal subjects. N Engl J Med (1973) 1.06
Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirin. Eur J Heart Fail (2003) 1.05
Depression in patients with coronary artery disease. Depression (1996) 1.05
A polymorphism in the tumor necrosis factor-alpha gene promoter region may predispose to a poor prognosis in COPD. Chest (2000) 1.04
Subxiphoid pericardiotomy in the diagnosis and management of large pericardial effusions associated with malignancy. Chest (1992) 1.04
Isolation and characterization of four inhibitors from wheat flour which display differential inhibition specificities for human salivary and human pancreatic alpha-amylases. Biochim Biophys Acta (1981) 1.04
Amyloidosis complicating cystic fibrosis. Thorax (1993) 1.02
The benefit of implementing a heart failure disease management program. Arch Intern Med (2001) 1.01
N.B.T. test. Lancet (1973) 1.01
Intestinal bile acid malabsorption in cystic fibrosis. Gut (1993) 1.00
Aortobrachiocephalic reconstruction. Am J Surg (1988) 1.00
Hypovitaminosis D and response to supplementation in older patients with cystic fibrosis. Q J Med (1985) 0.99
Continuous 12-lead ST-segment recovery analysis in the TAMI 7 study. Performance of a noninvasive method for real-time detection of failed myocardial reperfusion. Circulation (1993) 0.99
The quantitative genetics of maximal and basal rates of oxygen consumption in mice. Genetics (2001) 0.99
Specific recognition of altered polypeptides by widely distributed methyltransferases. Biochem Biophys Res Commun (1985) 0.98
Ability of heart rate variability to predict prognosis in patients with advanced congestive heart failure. Am J Cardiol (1997) 0.97
Spontaneous pneumomediastinum in pregnancy. Case report. Br J Obstet Gynaecol (1981) 0.97
Methylation of chicken fibroblast heat shock proteins at lysyl and arginyl residues. J Biol Chem (1982) 0.96
Methylation of erythrocyte membrane proteins at extracellular and intracellular D-aspartyl sites in vitro. Saturation of intracellular sites in vivo. J Biol Chem (1983) 0.96
Increased soluble platelet/endothelial cellular adhesion molecule-1 and osteonectin levels in patients with severe congestive heart failure. Independence of disease etiology, and antecedent aspirin therapy. Eur J Heart Fail (1999) 0.94
Reactive airways dysfunction syndrome (RADS) due to chlorine gas exposure. Ir J Med Sci (1991) 0.94
Biomechanical variables associated with Achilles tendinopathy in runners. Br J Sports Med (2008) 0.94
Crohn's colitis and sarcoidosis. Postgrad Med J (1986) 0.94
Upper airway obstruction caused by massive subcutaneous emphysema. Intensive Care Med (1984) 0.94
Cardiac troponins in congestive heart failure. Am Heart J (1999) 0.94
Is optimal angiotensin-converting enzyme inhibitor dosing neglected in elderly patients with heart failure? Am Heart J (1998) 0.93
Neutrophil adhesion molecule surface expression and responsiveness in cystic fibrosis. Am J Respir Crit Care Med (1998) 0.93
Hemostatic abnormalities in patients with congestive heart failure: diagnostic significance and clinical challenge. Int J Cardiol (2000) 0.93
Type I collagenases in bronchoalveolar lavage fluid from preterm babies at risk of developing chronic lung disease. Arch Dis Child Fetal Neonatal Ed (2001) 0.92
Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis. Reexamining the "gold standard" for myocardial reperfusion assessment. J Am Coll Cardiol (2000) 0.92
Patient work-up for bullectomy. J Thorac Imaging (1986) 0.92
Interleukin-8 and leukotriene-B(4), but not formylmethionyl leucylphenylalanine, stimulate CD18-independent migration of neutrophils across human pulmonary endothelial cells in vitro. Am J Respir Cell Mol Biol (2000) 0.91
Recurrent genital candidosis and iron metabolism. Br J Vener Dis (1977) 0.91
An alpha1-antitrypsin enhancer polymorphism is a genetic modifier of pulmonary outcome in cystic fibrosis. Eur J Hum Genet (2001) 0.90
Kinetic and electrophoretic analysis of transmethylation reactions in intact Xenopus laevis oocytes. J Biol Chem (1987) 0.90
Ultrastructure of lung elastin and collagen in mouse models of spontaneous emphysema. Matrix Biol (1999) 0.90
Mycoplasmal pericarditis: evidence of invasive disease. Clin Infect Dis (1993) 0.90